Dr Billy Ernest Jones, MD in Bath, NC - Dermatology

Dr Billy Ernest Jones, MD is a Dermatology physician based in Bath, North Carolina. Dr Billy Ernest Jones is licensed to practice in North Carolina (license number 11190) and his current practice location is 310 Teachs Cv, Bath, North Carolina. He can be reached at his office (for appointments etc.) via phone at (252) 923-6711.

NPI number for Dr Billy Ernest Jones is 1093039885 and his current mailing address is 310 Teachs Cv, Bath, North Carolina. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1093039885.

Contact Information

	Dr Billy Ernest Jones, MD
	310 Teachs Cv, Bath, NC 27808-9712
	(252) 923-6711
	(252) 923-6711

Physician's Profile

Full Name	Dr Billy Ernest Jones
Gender	Male
Speciality	Dermatology
Location	310 Teachs Cv, Bath, North Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1093039885
Provider Enumeration Date: 03/23/2010
Last Update Date: 03/23/2010

Medical Identifiers

Medical identifiers for Dr Billy Ernest Jones such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093039885	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	11190 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Billy Ernest Jones is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Billy Ernest Jones, MD 310 Teachs Cv, Bath, NC 27808-9712 Ph: (252) 923-6711	Dr Billy Ernest Jones, MD 310 Teachs Cv, Bath, NC 27808-9712 Ph: (252) 923-6711

News Archive

Washington personalities: Lobbyist Tauzin shakes it up; More on OMB director's impending departure

Roll Call: Billy Tauzin, the former Louisiana lawmaker, will leave his job as the president of the Pharmaceutical Research and Manufacturers of America next Wednesday, and part ways - for the first time in 18 years - with his trusty communications director, Ken Johnson. As Roll Call puts it, "The sun is setting on a K Street bromance." Tauzin is likely to start a lobbying firm with his son Tom or practice law in Texas, while Johnson will pursue other work. The two were said to be "attached at the hip" (Murray, 6/23).

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June issue of Developmental Cell, Shai Shaham, Ph.D., and graduate student Elliot Perens use the roundworm, C. elegans, to investigate the mysterious glial cell, which makes up 90 percent of the human brain and, when it malfunctions, can contribute to diseases like Parkinson's disease and schizophrenia.

Carnegie Mellon study identifies intermediary neuron system that acts as synaptic cloaking device

Neuroscientists believe that the connectome, a map of each and every connection between the millions of neurons in the brain, will provide a blueprint that will allow them to link brain anatomy to brain function. But a new study from Carnegie Mellon University has found that a specific type of neuron might be thwarting their efforts at mapping the connectome by temporarily cloaking the synapses that link a wide field of neurons.

Fewer high school students engage in health risk behaviors

Fewer U.S. high school students are engaging in health risk behaviors compared to their counterparts from 15 years ago, according to the 2005 National Youth Risk Behavior Survey (YRBS), released today by the Centers for Disease Control and Prevention (CDC).

Intracellular process of autophagy plays role in prostate cancer development, shows research

Research from investigators at Rutgers Cancer Institute of New Jersey and the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, shows the intracellular process of autophagy plays a role in the development of prostate cancer.

Dr Billy Ernest Jones, MD - Dermatology in Bath, NC